Because the number of the studies included in the current meta-analysis for each receptor is relatively small, we may need to accumulate more data to re-evaluate the significance of AR/ERα/ERβ expression in bladder cancer outgrowth. The gene discussed is ESR1; the disease is urinary bladder carcinoma.